Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
t-cell
lymphoma
standalone
investment
Pharmaceutical
SciTech
Drug Delivery
drug
nanofenretinide
ST-001
bioavailability
Immunotherapy
partnering
cancer
fenretinide
small cell lung cancer
phospholipid
SDP
Life Science
combination
Funding rounds raised
Total raised
$2.7M
from 3 investors over 3 rounds
S
SciTech Development LLC raised $2.7M on June 7, 2023
Investors: National Foundation for Cancer Research, Pointe Angels and Storm Lake Capital